Biopharma, the Kyiv-based producer of blood-derived products, is to boost exports by 40% this month, to $4.6 million.
Wednesday, August 22, 2018

Biopharma, the Kyiv-based producer of blood-derived products, is to boost exports by 40% this month, to $4.6 million.

Biopharma, the Kyiv-based producer of blood-derived products, is to boost exports by 40% this month, to $4.6 million. Already selling to eight countries, Biopharma adds Bangladesh and Colombia this month. Boosted by investment from Horizon Capital and FMO, the Dutch development bank, Biopharma has become Ukraine’s leader in producing blood plasma protein products.

Previous post
For comments and story tips, Brooke is reachable at:

For comments and story tips, Brooke is reachable at:

Next post
Ukraine’s shift to a cashless economy accelerates as payment cards during the first half accounted for 44% of transactions

Ukraine’s shift to a cashless economy accelerates as payment cards during the first half accounted for 44% of transactions

Previous Main Topics